Urinary orosomucoid: a new marker of cardiovascular risk in psoriatic patients?

Overview of attention for article published in Therapeutics and Clinical Risk Management, July 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 29 Mendeley

Summary Patents Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

Urinary Orosomucoid as a Potential Marker of Inflammation in Psoriasis Vulgaris

Article in The Egyptian Journal of Hospital Medicine (January 2024)

The Inflammatory and Oxidative Status of Newly Diagnosed Class III and Class IV Lupus Nephritis, with Six-Month Follow-Up

Article in Antioxidants (December 2023)

Causes of Autoimmune Psoriasis and Associated Cardiovascular Disease: Roles of Human Endogenous Retroviruses and Antihypertensive Drugs—A Systematic Review and Meta-analysis

Preprint in medRxiv (November 2023)